{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T06:16:18Z","timestamp":1793772978678,"version":"4.6.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T00:00:00Z","timestamp":1676592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T00:00:00Z","timestamp":1676592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002878","name":"Consejer\u00eda de Econom\u00eda, Innovaci\u00f3n, Ciencia y Empleo, Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["P10-CTS-0662"],"award-info":[{"award-number":["P10-CTS-0662"]}],"id":[{"id":"10.13039\/501100002878","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002878","name":"Consejer\u00eda de Econom\u00eda, Innovaci\u00f3n, Ciencia y Empleo, Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["P12-CTS-383"],"award-info":[{"award-number":["P12-CTS-383"]}],"id":[{"id":"10.13039\/501100002878","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003339","name":"Ministry of Economy and Competitiveness | Consejo Superior de Investigaciones Cient\u00edficas","doi-asserted-by":"publisher","award":["RTI2018-098968-B-I00"],"award-info":[{"award-number":["RTI2018-098968-B-I00"]}],"id":[{"id":"10.13039\/501100003339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Vasculogenic Mimicry (VM) refers to the capacity to form a blood network from aggressive cancer cells in an independent way of endothelial cells, to provide nutrients and oxygen leading to enhanced microenvironment complexity and treatment failure. In a previous study, we demonstrated that VE-Cadherin and its phosphorylation at Y658 modulated kaiso-dependent gene expression (CCND1 and Wnt 11) through a pathway involving Focal Adhesion kinase (FAK). In the present research, using a proteomic approach, we have found that \u03b2-catenin\/TCF-4 is associated with nuclear VE-cadherin and enhances the capacity of malignant melanoma cells to undergo VM in cooperation with VE-Cadherin; in addition, preventing the phosphorylation of Y658 of VE-cadherin upon FAK disabling resulted in VE-Cadherin\/\u03b2-catenin complex dissociation, increased \u03b2-catenin degradation while reducing TCF-4-dependent genes transcription (C-Myc and Twist-1). Uveal melanoma cells knockout for VE-Cadherin loses \u03b2-catenin expression while the rescue of VE-Cadherin (but not of the phosphorylation defective VE-Cadherin Y658F mutant) permits stabilization of \u03b2-catenin and tumor growth reduction in vivo experiments. In vivo, the concomitant treatment with the FAK inhibitor PF-271 and the anti-angiogenic agent bevacizumab leads to a strong reduction in tumor growth concerning the single treatment. In conclusion, the anomalous expression of VE-Cadherin in metastatic melanoma cells (from both uveal and cutaneous origins), together with its permanent phosphorylation at Y658, favors the induction of the aggressive VM phenotype through the cooperation of \u03b2-catenin with VE-Cadherin and by enhancing TCF-4 genes-dependent transcription.<\/jats:p>","DOI":"10.1038\/s41419-023-05666-7","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T22:04:37Z","timestamp":1676585077000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["VE-Cadherin modulates \u03b2-catenin\/TCF-4 to enhance Vasculogenic Mimicry"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9588-4747","authenticated-orcid":false,"given":"Daniel","family":"Delgado-Bellido","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban","family":"Zamudio-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Fern\u00e1ndez-Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Bel\u00e9n","family":"Herrera-Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquin","family":"Olmedo-Pelayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen Jord\u00e1n","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Exp\u00f3sito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8400-046X","authenticated-orcid":false,"given":"Enrique","family":"de \u00c1lava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Teresa","family":"Amaral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco O\u2019","family":"Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel Garcia","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8468-1998","authenticated-orcid":false,"given":"F. J.","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,17]]},"reference":[{"key":"5666_CR1","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/S0161-6420(97)30234-6","volume":"104","author":"IW McLean","year":"1997","unstructured":"McLean IW, Keefe KS, Burnier MN. Uveal melanoma: comparison of the prognostic value of fibrovascular loops, mean of the ten largest nucleoli, cell type, and tumor size. Ophthalmology. 1997;104:777\u201380.","journal-title":"Ophthalmology."},{"key":"5666_CR2","first-page":"473","volume":"7","author":"MA Warso","year":"2001","unstructured":"Warso MA, Maniotis AJ, Chen X, Majumdar D, Patel MK, Shilkaitis A, et al. Prognostic significance of periodic acid-schiff-positive patterns in primary cutaneous melanoma. Clin Cancer Res. 2001;7:473\u20137.","journal-title":"Clin Cancer Res"},{"key":"5666_CR3","doi-asserted-by":"publisher","first-page":"4664","DOI":"10.1158\/1078-0432.CCR-21-2433","volume":"27","author":"JS Paradis","year":"2021","unstructured":"Paradis JS, Acosta M, Saddawi-Konefka R, Kishore A, Lubrano S, Gomes FG, et al. Synthetic lethal screens reveal co-targeting FAK and MEK as a multimodal precision therapy for GNAQ-driven uveal melanoma. Clin Cancer Res. 2021;27:4664\u20134664.","journal-title":"Clin Cancer Res"},{"key":"5666_CR4","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S0002-9440(10)65173-5","volume":"155","author":"AJ Maniotis","year":"1999","unstructured":"Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LMG, Pe\u2019er J, et al. Vascular channel formation by human melanoma cells in vivo and in vitro: Vasculogenic mimicry. Am J Pathol. 1999;155:739\u201352.","journal-title":"Am J Pathol"},{"key":"5666_CR5","doi-asserted-by":"publisher","first-page":"8018","DOI":"10.1073\/pnas.131209798","volume":"98","author":"MJC Hendrix","year":"2001","unstructured":"Hendrix MJC, Seftor EA, Meltzer PS, Gardner LMG, Hess AR, Kirschmann DA, et al. Expression and functional significance of VE-cadherin in aggressive human melanoma cells: Role in vasculogenic mimicry. Proc Natl Acad Sci USA. 2001;98:8018\u201323.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5666_CR6","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/j.ophtha.2019.04.027","volume":"126","author":"P Vichitvejpaisal","year":"2019","unstructured":"Vichitvejpaisal P, Dalvin LA, Mazloumi M, Ewens KG, Ganguly A, Shields CL. Genetic analysis of uveal melanoma in 658 patients using the cancer genome atlas classification of uveal melanoma as A, B, C, and D. Ophthalmology. 2019;126:1445\u201353.","journal-title":"Ophthalmology."},{"key":"5666_CR7","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.ccell.2019.01.009","volume":"35","author":"X Feng","year":"2019","unstructured":"Feng X, Arang N, Rigiracciolo DC, Lee JS, Yeerna H, Wang Z, et al. A platform of synthetic lethal gene interaction networks reveals that the GNAQ uveal melanoma oncogene controls the hippo pathway through FAK. Cancer Cell. 2019;35:457\u201372.e5.","journal-title":"Cancer Cell"},{"key":"5666_CR8","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.biopha.2018.11.082","volume":"110","author":"X Cheng","year":"2019","unstructured":"Cheng X, Xu X, Chen D, Zhao F, Wang W. Therapeutic potential of targeting the Wnt\/\u03b2-catenin signaling pathway in colorectal cancer. Biomed Pharmacother. 2019;110:473\u201381.","journal-title":"Biomed Pharmacother"},{"key":"5666_CR9","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.3390\/cells9092125","volume":"9","author":"J Bian","year":"2020","unstructured":"Bian J, Dannappel M, Wan C, Firestein R. Transcriptional regulation of Wnt\/\u03b2-catenin pathway in colorectal cancer. Cells. 2020;9:2125.","journal-title":"Cells."},{"key":"5666_CR10","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/S0092-8674(00)80352-9","volume":"90","author":"AH Huber","year":"1997","unstructured":"Huber AH, Nelson WJ, Weis WI. Three-dimensional structure of the armadillo repeat region of \u03b2-catenin. Cell. 1997;90:871\u201382.","journal-title":"Cell."},{"key":"5666_CR11","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1128\/MCB.01466-10","volume":"31","author":"B del Valle-Perez","year":"2011","unstructured":"del Valle-Perez B, Arques O, Vinyoles M, de Herreros AG, Dunach M. Coordinated action of CK1 isoforms in canonical Wnt signaling. Mol Cell Biol. 2011;31:2877\u201388.","journal-title":"Mol Cell Biol"},{"key":"5666_CR12","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.molcel.2013.12.010","volume":"53","author":"M Vinyoles","year":"2014","unstructured":"Vinyoles M, DelValle-P\u00e9rez B, Curto J, Vi\u00f1as-Castells R, Alba-Castell\u00f3n L, Garc\u00eda de Herreros A, et al. Multivesicular GSK3 sequestration upon Wnt signaling is controlled by p120-catenin\/cadherin interaction with LRP5\/6. Mol Cell. 2014;53:444\u201357.","journal-title":"Mol Cell"},{"key":"5666_CR13","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/embj.201385358","volume":"33","author":"J Schuijers","year":"2014","unstructured":"Schuijers J, Mokry M, Hatzis P, Cuppen E, Clevers H. Wnt-induced transcriptional activation is exclusively mediated by TCF\/LEF. EMBO J. 2014;33:146\u201356.","journal-title":"EMBO J"},{"key":"5666_CR14","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41418-018-0125-4","volume":"26","author":"D Delgado-Bellido","year":"2019","unstructured":"Delgado-Bellido D, Fern\u00e1ndez-Cort\u00e9s M, Rodr\u00edguez MI, Serrano-S\u00e1enz S, Carracedo A, Garcia-Diaz A, et al. VE-cadherin promotes vasculogenic mimicry by modulating kaiso-dependent gene expression. Cell Death Differ. 2019;26:348\u201361.","journal-title":"Cell Death Differ"},{"key":"5666_CR15","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1083\/jcb.129.1.203","volume":"129","author":"MG Lampugnani","year":"1995","unstructured":"Lampugnani MG, Corada M, Caveda L, Breviario F, Ayalon O, Geiger B, et al. The molecular organization of endothelial cell to cell junctions: differential association of plakoglobin, \u03b2-catenin, and \u03b1-catenin with vascular endothelial cadherin (VE-cadherin). J Cell Biol. 1995;129:203\u201317.","journal-title":"J Cell Biol"},{"key":"5666_CR16","doi-asserted-by":"publisher","first-page":"C977","DOI":"10.1152\/ajpcell.90607.2007","volume":"294","author":"M Guo","year":"2008","unstructured":"Guo M, Breslin JW, Wu MH, Gottardi CJ, Yuan SY. VE-cadherin and \u03b2-catenin binding dynamics during histamine-induced endothelial hyperpermeability. Am J Physiol - Cell Physiol. 2008;294:C977\u201384.","journal-title":"Am J Physiol - Cell Physiol"},{"key":"5666_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07302-x","volume":"9","author":"K H\u00fcbner","year":"2018","unstructured":"H\u00fcbner K, Cabochette P, Di\u00e9guez-Hurtado R, Wiesner C, Wakayama Y, Grassme KS, et al. Wnt\/\u03b2-catenin signaling regulates VE-cadherin-mediated anastomosis of brain capillaries by counteracting S1pr1 signaling. Nat Commun. 2018;9:4860.","journal-title":"Nat Commun"},{"key":"5666_CR18","doi-asserted-by":"publisher","first-page":"106113","DOI":"10.15252\/embj.2020106113","volume":"40","author":"N Arif","year":"2021","unstructured":"Arif N, Zinnhardt M, Nyamay\u2019Antu A, Teber D, Br\u00fcckner R, Schaefer K, et al. PECAM\u20101 supports leukocyte diapedesis by tension\u2010dependent dephosphorylation of VE\u2010cadherin. EMBO J. 2021;40:106113.","journal-title":"EMBO J"},{"key":"5666_CR19","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1161\/CIRCRESAHA.117.312392","volume":"122","author":"MF Morini","year":"2018","unstructured":"Morini MF, Giampietro C, Corada M, Pisati F, Lavarone E, Cunha SI, et al. VE-cadherin-mediated epigenetic regulation of endothelial gene expression. Circ Res. 2018;122:231\u201345.","journal-title":"Circ Res"},{"key":"5666_CR20","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1242\/jcs.017897","volume":"121","author":"E Dejana","year":"2008","unstructured":"Dejana E, Orsenigo F, Lampugnani MG. The role of adherens junctions and VE-cadherin in the control of vascular permeability. J Cell Sci. 2008;121:2115\u201322.","journal-title":"J Cell Sci"},{"key":"5666_CR21","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1083\/jcb.201307067","volume":"204","author":"C Jean","year":"2014","unstructured":"Jean C, Chen XL, Nam JO, Tancioni I, Uryu S, Lawson C, et al. Inhibition of endothelial FAK activity prevents tumor metastasis by enhancing barrier function. J Cell Biol. 2014;204:247\u201363.","journal-title":"J Cell Biol"},{"key":"5666_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1411-x","volume":"10","author":"S Liu","year":"2019","unstructured":"Liu S, Ni C, Zhang D, Sun H, Dong X, Che N, et al. S1PR1 regulates the switch of two angiogenic modes by VE-cadherin phosphorylation in breast cancer. Cell Death Dis. 2019;10:200.","journal-title":"Cell Death Dis"},{"key":"5666_CR23","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/path.5152","volume":"246","author":"VLJL Thijssen","year":"2018","unstructured":"Thijssen VLJL, Paulis YWJ, Nowak-Sliwinska P, Deumelandt KL, Hosaka K, Soetekouw PMMB, et al. Targeting PDGF-mediated recruitment of pericytes blocks vascular mimicry and tumor growth. J Pathol. 2018;246:447\u201358.","journal-title":"J Pathol"},{"key":"5666_CR24","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13046-017-0533-1","volume":"36","author":"M Wang","year":"2017","unstructured":"Wang M, Zhao X, Zhu D, Liu T, Liang X, Liu F, et al. HIF-1\u03b1 promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment. J Exp Clin Cancer Res. 2017;36:60.","journal-title":"J Exp Clin Cancer Res"},{"key":"5666_CR25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.devcel.2009.06.016","volume":"17","author":"BT MacDonald","year":"2009","unstructured":"MacDonald BT, Tamai K, He X. Wnt\/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell. 2009;17:9\u201326.","journal-title":"Dev Cell"},{"key":"5666_CR26","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/S0960-9822(00)00752-1","volume":"10","author":"S Smith","year":"2000","unstructured":"Smith S, De Lange T. Tankyrase promotes telomere elongation in human cells. Curr Biol. 2000;10:1299\u2013302.","journal-title":"Curr Biol"},{"key":"5666_CR27","doi-asserted-by":"publisher","first-page":"4611","DOI":"10.1111\/bph.14038","volume":"174","author":"L Mariotti","year":"2017","unstructured":"Mariotti L, Pollock K, Guettler S. Regulation of Wnt\/\u03b2-catenin signalling by tankyrase-dependent poly(ADP-ribosyl)ation and scaffolding. Br J Pharmacol. 2017;174:4611\u201336.","journal-title":"Br J Pharmacol"},{"key":"5666_CR28","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ctrv.2017.11.002","volume":"62","author":"N Krishnamurthy","year":"2018","unstructured":"Krishnamurthy N, Kurzrock R. Targeting the Wnt\/beta-catenin pathway in cancer: update on effectors and inhibitors. Cancer Treat Rev. 2018;62:50\u201360.","journal-title":"Cancer Treat Rev"},{"key":"5666_CR29","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s13046-021-01950-6","volume":"40","author":"E Zamudio-Martinez","year":"2021","unstructured":"Zamudio-Martinez E, Herrera-Campos AB, Mu\u00f1oz A, Rodr\u00edguez-Vargas JM, Oliver FJ. Tankyrases as modulators of pro-tumoral functions: molecular insights and therapeutic opportunities. J Exp Clin Cancer Res. 2021;40:144.","journal-title":"J Exp Clin Cancer Res"},{"key":"5666_CR30","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3389\/fonc.2020.00018","volume":"10","author":"D Delgado-Bellido","year":"2020","unstructured":"Delgado-Bellido D, Bueno-Galera C, L\u00f3pez-Jim\u00e9nez L, Garcia-Diaz A, Oliver FJ. Endothelial phosphatase VE-PTP participates in vasculogenic mimicry by preventing autophagic degradation of VE-cadherin. Front Oncol. 2020;10:18.","journal-title":"Front Oncol"},{"key":"5666_CR31","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1158\/1535-7163.MCT-06-0476","volume":"6","author":"TJ Liu","year":"2007","unstructured":"Liu TJ, LaFortune T, Honda T, Ohmori O, Hatakeyama S, Meyer T, et al. Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivo. Mol Cancer Ther. 2007;6:1357\u201367.","journal-title":"Mol Cancer Ther"},{"key":"5666_CR32","doi-asserted-by":"publisher","first-page":"778","DOI":"10.4161\/cbt.9.10.11433","volume":"9","author":"C Walsh","year":"2010","unstructured":"Walsh C, Tanjoni I, Uryu S, Tomar A, Nam JO, Luo H, et al. Oral delivery of PND-1186 FAK inhibitor decreases tumor growth and spontaneous breast to lung metastasis in pre-clinical models. Cancer Biol Ther. 2010;9:778\u201390.","journal-title":"Cancer Biol Ther"},{"key":"5666_CR33","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s10585-012-9562-5","volume":"30","author":"KK Ward","year":"2013","unstructured":"Ward KK, Tancioni I, Lawson C, Miller NLG, Jean C, Chen XL, et al. Inhibition of focal adhesion kinase (FAK) activity prevents anchorage-independent ovarian carcinoma cell growth and tumor progression. Clin Exp Metastasis. 2013;30:579\u201394.","journal-title":"Clin Exp Metastasis"},{"key":"5666_CR34","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1038\/nm.4197","volume":"22","author":"S Frentzas","year":"2016","unstructured":"Frentzas S, Simoneau E, Bridgeman VL, Vermeulen PB, Foo S, Kostaras E, et al. Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases. Nat Med. 2016;22:1294\u2013302.","journal-title":"Nat Med"},{"key":"5666_CR35","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/cjp2.100","volume":"4","author":"A Lazaris","year":"2018","unstructured":"Lazaris A, Amri A, Petrillo SK, Zoroquiain P, Ibrahim N, Salman A, et al. Vascularization of colorectal carcinoma liver metastasis: insight into stratification of patients for anti-angiogenic therapies. J Pathol Clin Res. 2018;4:184\u201392.","journal-title":"J Pathol Clin Res"},{"key":"5666_CR36","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1158\/0008-5472.CAN-10-2602","volume":"71","author":"E Di Tomaso","year":"2011","unstructured":"Di Tomaso E, Snuderl M, Kamoun WS, Duda DG, Auluck PK, Fazlollahi L, et al. Glioblastoma recurrence after cediranib therapy in patients: lack of \u201crebound\u201d revascularization as mode of escape. Cancer Res. 2011;71:19\u201328.","journal-title":"Cancer Res"},{"key":"5666_CR37","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nrc.2018.14","volume":"18","author":"T Donnem","year":"2018","unstructured":"Donnem T, Reynolds AR, Kuczynski EA, Gatter K, Vermeulen PB, Kerbel RS, et al. Non-angiogenic tumours and their influence on cancer biology. Nat Rev Cancer. 2018;18:323\u201336.","journal-title":"Nat Rev Cancer"},{"key":"5666_CR38","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/s41591-021-01331-8","volume":"27","author":"D Liu","year":"2021","unstructured":"Liu D, Lin JR, Robitschek EJ, Kasumova GG, Heyde A, Shi A, et al. Evolution of delayed resistance to immunotherapy in a melanoma responder. Nat Med. 2021;27:985\u201392.","journal-title":"Nat Med"},{"key":"5666_CR39","first-page":"65","volume":"18","author":"H Kurz","year":"2003","unstructured":"Kurz H, Burri PH, Djonov VG. Angiogenesis and vascular remodeling by intussusception: from form to function. N Physiol Sci. 2003;18:65\u201370.","journal-title":"N Physiol Sci"},{"key":"5666_CR40","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1056\/NEJMoa032691","volume":"350","author":"H Hurwitz","year":"2004","unstructured":"Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004;350:2335\u201342.","journal-title":"N Engl J Med"},{"key":"5666_CR41","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/ncponc0403","volume":"3","author":"RK Jain","year":"2006","unstructured":"Jain RK, Duda DG, Clark JW, Loeffler JS. Lessons from phase III clinical trials on anti-VEGF therapy for cancer. Nat Clin Pract Oncol. 2006;3:24\u201340.","journal-title":"Nat Clin Pract Oncol"},{"key":"5666_CR42","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1056\/NEJMoa021491","volume":"349","author":"JC Yang","year":"2003","unstructured":"Yang JC, Haworth L, Sherry RM, Hwu P, Schwartzentruber DJ, Topalian SL, et al. A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. N Engl J Med. 2003;349:427\u201334.","journal-title":"N Engl J Med"},{"key":"5666_CR43","first-page":"15","volume":"15","author":"S Zhang","year":"2006","unstructured":"Zhang S, Guo H, Zhang D, Zhang W, Zhao X, Ren Z, et al. Microcirculation patterns in different stages of melanoma growth. Oncol Rep. 2006;15:15\u201320.","journal-title":"Oncol Rep"},{"key":"5666_CR44","doi-asserted-by":"crossref","unstructured":"Wechman SL, Emdad L, Sarkar D, Das SK, Fisher PB. Vascular mimicry: triggers, molecular interactions and in vivo models. Adv Cancer Res. 2020;148:27\u201367.","DOI":"10.1016\/bs.acr.2020.06.001"},{"key":"5666_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-017-0631-x","volume":"16","author":"D Delgado-Bellido","year":"2017","unstructured":"Delgado-Bellido D, Serrano-Saenz S, Fern\u00e1ndez-Cort\u00e9s M, Oliver FJ. Vasculogenic mimicry signaling revisited: focus on non-vascular VE-cadherin. Mol Cancer. 2017;16:65.","journal-title":"Mol Cancer"},{"key":"5666_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30556-5","volume":"13","author":"A Byron","year":"2022","unstructured":"Byron A, Griffith BGC, Herrero A, Loftus AEP, Koeleman ES, Kogerman L, et al. Characterisation of a nucleo-adhesome. Nat Commun. 2022;13:3053.","journal-title":"Nat Commun"},{"key":"5666_CR47","doi-asserted-by":"crossref","unstructured":"McCrea PD, Maher MT, Gottardi CJ. Nuclear signaling from cadherin adhesion complexes. Curr Top Dev Biol. 2015;112:129\u201396.","DOI":"10.1016\/bs.ctdb.2014.11.018"},{"key":"5666_CR48","doi-asserted-by":"publisher","first-page":"12691","DOI":"10.1074\/jbc.M708887200","volume":"283","author":"EC Ferber","year":"2008","unstructured":"Ferber EC, Kajita M, Wadlow A, Tobiansky L, Niessen C, Ariga H, et al. A role for the cleaved cytoplasmic domain of E-cadherin in the nucleus. J Biol Chem. 2008;283:12691\u2013700.","journal-title":"J Biol Chem"},{"key":"5666_CR49","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.bbamcr.2006.08.052","volume":"1773","author":"JM Daniel","year":"2007","unstructured":"Daniel JM. Dancing in and out of the nucleus: p120ctn and the transcription factor Kaiso. Biochim Biophys Acta - Mol Cell Res. 2007;1773:59\u201368.","journal-title":"Biochim Biophys Acta - Mol Cell Res"},{"key":"5666_CR50","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1158\/1541-7786.MCR-18-0637","volume":"17","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, Yu T, Zhang N, Chen J, Zhang P, Li S, et al. Nuclear e-cadherin acetylation promotes colorectal tumorigenesis via enhancing \u03b2-catenin activity. Mol Cancer Res. 2019;17:655\u201365.","journal-title":"Mol Cancer Res"},{"key":"5666_CR51","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1517\/14728220903460340","volume":"14","author":"J Schwock","year":"2010","unstructured":"Schwock J, Dhani N, Hedley DW. Targeting focal adhesion kinase signaling in tumor growth and metastasis. Expert Opin Ther Targets. 2010;14:77\u201394.","journal-title":"Expert Opin Ther Targets"},{"key":"5666_CR52","doi-asserted-by":"publisher","first-page":"109253","DOI":"10.1016\/j.celrep.2021.109253","volume":"35","author":"LA Teuwen","year":"2021","unstructured":"Teuwen LA, De Rooij LPMH, Cuypers A, Rohlenova K, Dumas SJ, Garc\u00eda-Caballero M, et al. Tumor vessel co-option probed by single-cell analysis. Cell Rep. 2021;35:109253.","journal-title":"Cell Rep"},{"key":"5666_CR53","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s10456-021-09797-3","volume":"24","author":"A Pasut","year":"2021","unstructured":"Pasut A, Becker LM, Cuypers A, Carmeliet P. Endothelial cell plasticity at the single-cell level. Angiogenesis. 2021;24:311\u201326.","journal-title":"Angiogenesis."},{"key":"5666_CR54","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/pcmr.12345","volume":"28","author":"X Yu","year":"2015","unstructured":"Yu X, Ambrosini G, Roszik J, Eterovic AK, Stempke-Hale K, Seftor EA, et al. Genetic analysis of the \u201cuveal melanoma\u201d C918 cell line reveals atypical BRAF and common KRAS mutations and single tandem repeat profile identical to the cutaneous melanoma C8161 cell line. Pigment Cell Melanoma Res. 2015;28:357\u20139.","journal-title":"Pigment Cell Melanoma Res"},{"key":"5666_CR55","doi-asserted-by":"publisher","first-page":"4697","DOI":"10.1167\/iovs.08-2324","volume":"49","author":"R Folberg","year":"2008","unstructured":"Folberg R, Kadkol SHS, Frenkel S, Valyi-Nagy K, Jager MJ, Pe\u2019er J, et al. Authenticating cell lines in ophthalmic research laboratories. Investig Ophthalmol Vis Sci. 2008;49:4697\u2013701.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"5666_CR56","doi-asserted-by":"publisher","first-page":"24538","DOI":"10.1074\/jbc.M116.746370","volume":"291","author":"A Pozner","year":"2016","unstructured":"Pozner A, Terooatea TW, Buck-Koehntop BA. Cell-specific Kaiso (ZBTB33) regulation of cell cycle through cyclin D1 and cyclin E. J Biol Chem. 2016;291:24538\u201350.","journal-title":"J Biol Chem"},{"key":"5666_CR57","doi-asserted-by":"publisher","unstructured":"Rockstroh M, M\u00fcller SA, Jende C, Kerzhner A, Von Bergen M, Tomm JM. Cell fractionation\u2014an important tool for compartment proteomics. J Integr OMICS. 2011. https:\/\/doi.org\/10.5584\/JIOMICS.V1I1.52.","DOI":"10.5584\/JIOMICS.V1I1.52"},{"key":"5666_CR58","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nmeth1015","volume":"4","author":"GY Lee","year":"2007","unstructured":"Lee GY, Kenny PA, Lee EH, Bissell MJ. Three-dimensional culture models of normal and malignant breast epithelial cells. Nat Methods. 2007;4:359\u201365.","journal-title":"Nat Methods"},{"key":"5666_CR59","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.redox.2021.101885","volume":"41","author":"JM Mart\u00ed","year":"2021","unstructured":"Mart\u00ed JM, Garcia-Diaz A, Delgado-Bellido D, O\u2019Valle F, Gonz\u00e1lez-Flores A, Carlevaris O, et al. Selective modulation by PARP-1 of HIF-1\u03b1-recruitment to chromatin during hypoxia is required for tumor adaptation to hypoxic conditions. Redox Biol. 2021;41:41.","journal-title":"Redox Biol"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-05666-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-05666-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-05666-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T00:10:38Z","timestamp":1676592638000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-05666-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,17]]},"references-count":59,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["5666"],"URL":"https:\/\/doi.org\/10.1038\/s41419-023-05666-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2069549\/v1","asserted-by":"object"}]},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,17]]},"assertion":[{"value":"15 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"These studies were approved and performed in strict accordance with the recommendations of the Ethic and Research Committee of Virgen del Rocio University Hospital, Seville. The study was conducted by the Declaration of Helsinki and approved by the Institutional Review Board (or Ethics Committee) of Hospital Universitario Virgen del Roc\u00edo-Instituto de Biomedicina de Sevilla Biobank (Andalusian Public Health System Biobank and ISCIII-Red de Biobancos PT13\/0010\/0056) for studies involving humans. All animal experiments were conducted by protocols and conditions approved by the European guidelines (EU Directive 2010\/63\/EU). Protocols were approved by the local institution and the Direcci\u00f3n General de la Producci\u00f3n Agr\u00edcola y Ganadera de la Junta de Andaluc\u00eda in Spain.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"135"}}